NORWELL, Mass., July 14 Concert Medical, LLC today announced the launch of the "Conductor(TM)" family of Interventional Coronary Guidewires to the U.S. market. These guidewires are designed to address an extensive range of coronary disease cases at a superior value. The FDA granted Concert Medical clearance for the use and sale in the U.S. of the Conductor product line in September 2009. Concert Medical is located in Norwell, Mass. and manufactures all of its interventional products in the United States.
Advertisement
Concert Medical is an integrated medical device manufacturer, directly controlling all design and critical manufacturing processes for its interventional products. This business integration ensures both product quality and greater value. Concert's Conductor guidewires offer enhanced trackability and crossability, with an increased reliable strength and superior torque response. Performance-enhancing design features include a proprietary hydrophilic coating to improve tactile feel and shaft markers at 90cm and 100cm for precise insertion measurement.
Advertisement
Howard Donnelly, President of Concert Medical, said the Conductor is the firm's second guidewire product released in 2010. "Earlier this year we launched a private-labeled neurological guidewire, co-developed with a leading medical device company," noted Donnelly. "The Conductor, which we spent two years developing, is an outstanding addition to our interventional guidewire business."
Concert Medical, formerly The MicroSpring Company, was founded in 1982 as an exclusively contract manufacturer and was acquired by Donnelly and his partners in 2005. Since the acquisition, Donnelly has moved Concert from a contract manufacturer to a private label and proprietary medical device product developer. "Whether it's for our own product line or private labeled for a customer, we add a lot of value to the design and manufacturing of medical products," noted Donnelly. "With close to 30 years of experience in the fields of Interventional Cardiology and Interventional Neurology, we have the knowledge, expertise, and resources to bring innovative products and updates to the marketplace."
Interventional Cardiologists interested in the Conductor can contact Emily O'Connor, Product Manager, at 781-871-7882, x151 or at [email protected]. For additional information on Concert Medical and its products, visit www.concertmedical.com.
SOURCE Concert Medical, LLC
